HBeAg阴性慢性乙型肝炎的阿德福韦酯长期治疗(论著)
Long-Term Therapy with Adefovir Dipivoxil for
HBeAg-Negative Chronic Hepatitis B
Stephanos J. Hadziyannis, M.D., Nicolaos C. Tassopoulos, M.D., E. Jenny Heathcote,
M.D., Ting-Tsung Chang, M.D., George Kitis, M.D., Mario Rizzetto, M.D., Patrick Marcellin, M.D., Seng Gee Lim, M.D., Zachary Goodman, M.D., Jia Ma, M.S., Sarah Arterburn, M.S., Shelly Xiong, Ph.D., Graeme Currie, Ph.D., and Carol L. Brosgart, M.D., for the Adefovir Dipivoxil 438 Study Group*
详情请参照《中国医学论坛报》, 百拇医药
HBeAg-Negative Chronic Hepatitis B
Stephanos J. Hadziyannis, M.D., Nicolaos C. Tassopoulos, M.D., E. Jenny Heathcote,
M.D., Ting-Tsung Chang, M.D., George Kitis, M.D., Mario Rizzetto, M.D., Patrick Marcellin, M.D., Seng Gee Lim, M.D., Zachary Goodman, M.D., Jia Ma, M.S., Sarah Arterburn, M.S., Shelly Xiong, Ph.D., Graeme Currie, Ph.D., and Carol L. Brosgart, M.D., for the Adefovir Dipivoxil 438 Study Group*
详情请参照《中国医学论坛报》, 百拇医药